Surface Modification of Nanoparticles for Targeted Drug Delivery

Understanding the Surface Characteristics of Nanoparticles.- Surface Modification of Nanoparticles for Targeted Drug Delivery.- Surface-Modified PLGA Nanoparticles for Targeted Drug Delivery to Neurons.- Nanoparticles for Site Specific Drug Delivery.- Stealth Properties of Nanoparticles against Cancer: Surface Modification of NPs for Passive Targeting to Human Cancer Tissue in Zebra Fish.- Passive targeting of nanoparticles to cancer.- Surface Modification of Magnetic Nanoparticles in Biomedicine.- A novel strategy for the surface modification of super paramagnetic (Fe3O4) iron oxide nanoparticle for lung cancer imaging.- Biodegradable nanoparticles for drug delivery and targeting.- Functionalized antibacterial nanoparticles in controlling biofilm and intracellular infections.- Surface modifications of liposomes for drug targeting.- Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system.- Surface Modification of Metallic Nano particles.- Successful Delivery of Zidovudine-loaded Docosanol Nanostructured Lipid Carriers (Docosanol NLCs) into rat brain.- Brain targeted drug delivery with surface modified nanoparticles.- Surface Modification of Resorcinarene Based Self-Assembled Solid Lipid Nanoparticles for Drug Targeting.- Targeted delivery of surface modified nanoparticles:Modulation of inflammation for acute lung injury.- Surface modification of Nano carriers for specific cell targeting for better therapeutic effect.- Polydopamine-Based Simple and Versatile Surface Modification of Polymeric Nano Drug Carriers.- Surface modification of Nano carriers for specific cell targeting for better therapeutic effect.- Polydopamine-Based Simple and Versatile Surface Modification of Polymeric Nano Drug Carriers.- Surface Modification of Gold Nanoparticles for Targeted Drug Delivery.- Surface modification and bioconjugation of nanoparticles for MRI technology.- Surface Modified Lanthanide Nanomaterials for Drug Delivery.- Engineering of targeted

Prof. Yashwant Pathak, M.S., Ph.D. in Pharmaceutical Technology from Nagpur University, India and EMBA and MS in Conflict Management from Sullivan University, KY, USA. He is the Associate Dean for Faculty Affairs at the College of Pharmacy, University of South Florida. Tampa, Florida. With extensive experience in academia as well as industry, he has to his credit more than 100 publications and 2 patents, including 5 books in Nanotechnology and 2 in Nutraceuticals and several books in cultural studies. He is also the Coordinator for the International Center for Cultural Studies, and is on the board of many organizations.